Effects of heparin and cholesterol sulfate on the activity and stability of human matrix metalloproteinase 7

References

• Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145–2154.
   PubMed Web of Science ®Google Scholar
• Matrisian LM. The matrix degrading metalloproteinases. BioEssays. 1992;14:455–463.
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner JF Jr. Matrix metalloproteinases. J. Biol. Chem. 1999;274:21491–21494.
   PubMed Web of Science ®Google Scholar
• Woessner JF Jr, Taplin CJ. Purification and properties of a small latent matrix metallo-proteinase of the rat uterus. J. Biol. Chem. 1988;263:16918–16925.
   PubMed Web of Science ®Google Scholar
• Browner MF, Smith WW, Castelhano AL. Matrilysin-inhibitor complexes: common themes among metalloproteases. Biochemistry. 1995;34:6602–6610.
   PubMed Web of Science ®Google Scholar
• Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT. Expression of metalloproteinase genes in human prostate cancer. J. Cancer Res. Clin. Oncol. 1991;117:144–150.
   PubMed Web of Science ®Google Scholar
• Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K, Yachi A. Expression of MMP-7 (PUMP-1) mRNA in human colorectal cancers. Int. J. Cancer. 1993;54:614–618.
   PubMedGoogle Scholar
• Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg. 1995;83:298–307.
   PubMed Web of Science ®Google Scholar
• Adachi Y, Itoh F, Yamamoto H, Matsuno K, Arimura Y, Kusano M, Endo T, Hinoda Y, Oohara M, Hosokawa M, Imai K. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int. J. Oncol. 1998;13:1031–1035.
   PubMed Web of Science ®Google Scholar
• Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H, Dumont P, Eber M, Abecassis J. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int. J. Cancer. 1991;48:550–556.
   PubMed Web of Science ®Google Scholar
• Happner kJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumour-induced host response. Am. J. Pathol. 1996;149:273–282.
   PubMed Web of Science ®Google Scholar
• Muta Y, Oneda H, Inouye K. Inhibitory effects of alcohols on the activity of human matrix metalloproteinase 7 (matrilysin). Biosci. Biotechnol. Biochem. 2004;68:2649–2652.
   PubMed Web of Science ®Google Scholar
• Oneda H, Inouye K. Interactions of human matrix metalloproteinase 7 (matrilysin) with the inhibitors thiorphan and R-94138. J. Biochem. 2001;129:429–435.
   Google Scholar
• Muta Y, Oyama S, Umezawa T, Shimada M, Inouye K. Inhibitory effects of lignans on the activity of human matrix metalloproteinase 7 (matrilysin). J. Agric. Food Chem. 2004;52:5888–5894.
   Google Scholar
• Oneda H, Shiihara M, Inouye K. Inhibitory effects of green tea catechins on the activity of human matrix metalloproteinase 7 (matrilysin). J. Biochem. 2003;133:571–576.
   Google Scholar
• Miyake T, Yasukawa K, Inouye K. Analysis of the mechanism of inhibition of human matrix metalloproteinase 7 (MMP-7) activity by green tea catechins. Biosci. Biotechnol. Biochem. 2011;75:1564–1569.
   PubMed Web of Science ®Google Scholar
• Samukange V, Yasukawa K, Inouye K. Interaction of 8-anilinonaphthalene 1-sulphonate (ANS) and human matrix metalloproteinase 7 (MMP-7) as examined by MMP-7 activity and ANS fluorescence. J. Biochem. 2012;151:533–540.
   Google Scholar
• Muta Y, Oneda H, Inouye K. Anomalous pH-dependence of the activity of human matrilysin (matrix metalloproteinase-7) as revealed by nitration and amination of its tyrosine residues. Biochem. J. 2005;386:263–270.
   PubMed Web of Science ®Google Scholar
• Muta Y, Inouye K. Tyr219 of human matrix metalloproteinase 7 (MMP-7) is not critical for catalytic activity, but is involved in the broad pH-dependence of the activity. J. Biochem. 2011;150:183–188.
   Google Scholar
• Takeharu H, Yasukawa K, Inouye K. Thermodynamic analysis of ionizable groups involved in the catalytic mechanism of human matrix metalloproteinase 7 (MMP-7). Biochim. Biophys. Acta. 2011;1814:1940–1946.
   Google Scholar
• Morishima A, Yasukawa K, Inouye K. A possibility of a protein-bound water molecule as the ionizable group responsible for pKe at the alkaline side in human matrix metalloproteinase 7 activity. J. Biochem. 2012;151:501–509.
   Google Scholar
• Yu WH, Woessner JF Jr. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 2000;275:4183–4191.
   PubMed Web of Science ®Google Scholar
• Yu WH, Woessner JF Jr. Heparin-enhanced zymographic detection of matrilysin and collagenases. Anal. Biochem. 2001;293:38–42.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Higashi S, Kioi M, Tsunezumi J, Honke K, Miyazaki K. Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion. J. Biol. Chem. 2006;281:9170–9180.
   PubMed Web of Science ®Google Scholar
• Higashi S, Oeda M, Yamamoto K, Miyazaki K. Identification of amino acid residues of matrix metalloproteinase 7 essential for binding to cholesterol sulfate. J. Biol. Chem. 2008;283:35735–35744.
   Google Scholar
• Yamamoto K, Miyazaki K, Higashi S. Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin. J. Biol. Chem. 2010;285:28862–28873.
   PubMedGoogle Scholar
• Knight CG, Willenbrock F, Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 1992;296:263–266.
   PubMed Web of Science ®Google Scholar
• Muta Y, Yasui N, Matsumiya Y, Kubo M, Inouye K. Expression in Escherichia coli, refolding, and purification of the recombinant mature form of human matrix metalloproteinase 7 (MMP-7). Biosci. Biotechnol. Biochem. 2010;74:2515–2517.
   PubMed Web of Science ®Google Scholar
• Oneda H, Inouye K. Refolding and recovery of recombinant human matrix metalloproteinase 7 (matrilysin) from inclusion bodies expressed by Escherichia Coli. J. Biochem. 1999;126:905–911.
   Google Scholar
• Oneda H, Inouye K. Effects of dimethyl sulfoxide, temperature, and sodium chloride on the activity of human matrix metalloproteinase 7 (matrilysin). J. Biochem. 2000;128:785–791.
   Google Scholar
• Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 1991;60:443–475.
   PubMed Web of Science ®Google Scholar
• Gambetti S, Dondi A, Cervellati C, Squerzanti M, Pansini FS, Bergamini CM. Interaction with heparin protects tissue transglutaminase against inactivation by heating and by proteolysis. Biochimie. 2005;87:551–555.
   Google Scholar
• O’Farrell F, Loog M, Janson IM, Ek P. Kinetic study of the inhibition of CK2 by heparin fragments of different length. Biochim. Biophys. Acta. 1999;1433:68–75.
   Google Scholar
• Ganguly B, Banerjee J, Elegbede AI, Klocke DJ, Mallik S, Srivastava DK. Intrinsic selectivity in binding of matrix metalloproteinase-7 to differently charged lipid membranes. FEBS Lett. 2007;581:5723–5726.
   Google Scholar
• Vemuri S, Beylin I, Sluzky V, Stratton P, Eberlein G, Wang YJ. The stability of bFGF against thermal denaturation. J. Pharm. Pharmacol. 1994;46:481–486.
   PubMed Web of Science ®Google Scholar
• Bugs MR, Bortoleto-Bugs RK, Cornélio ML. The interaction between heparin and Lys49 phospholipase A2 reveals the natural binding of heparin on the enzyme. Int. J. Biol. Macromol. 2005;37:21–27.
   PubMed Web of Science ®Google Scholar
• Golabek AA, Walus M, Wisniewski KE, Kida E. Glycosaminoglycans modulate activation, activity, and stability of tripeptidyl-peptidase I in vitro and in vivo. J. Biol. Chem. 2005;280:7550–7561.
   Google Scholar
• Bágel’ová J, Antalík M, Bona M. Studies on cytochrome c-heparin interactions by differential scanning calorimetry. Biochem. J. 1994;297:99–101.
   PubMed Web of Science ®Google Scholar
• Strott CA, Higashi Y. Cholesterol sulfate in human physiology: what’s it all about? J. Lipid Res. 2003;44:1268–1278.
   PubMed Web of Science ®Google Scholar
• Nakae H, Hiroi H, Momoeda M, Koizumi M, Iwamori M, Taketani Y. Inhibition of cell invasion and protease activity by cholesterol sulfate. Fertil. Steril. 2010;94:2455–2457.
   Google Scholar
• Kallen J, Schlaeppi JM, Bitsch F, Delhon I, Fournier B. Crystal structure of the human RORα ligand binding domain in complex with cholesterol sulfate at 2.2 Å. J. Biol. Chem. 2004;279:14033–14038.
   PubMed Web of Science ®Google Scholar